FindTrial
Sign In

Treatment of Alopecia Using Follicular Stem Cells

Treatment of Alopecia Using Follicular Stem Cells

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05210452
Enrollment
30
Registered
2022-01-27
Start date
2022-03-01
Completion date
2023-12-31
Last updated
2022-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia

Brief summary

Treatment of alopecia using the injections of cultured stem cells from human hair follicles,(which contain epithelial and mesenchymal cells stem cell)

Detailed description

The aim of the project is to develop a biomedical cell product based on and stem progenitor cells of the hair follicle and dermal papilla, to study its efficacy in the treatment of alopecia.

Interventions

BIOLOGICALFollicular stem cells

Cultured autologous follicular stem cells

OTHERStandard treatment according to the clinical protocols

Standard treatment of alopecia according to the clinical protocols

Sponsors

Belarusian State Medical University
CollaboratorOTHER
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of alopecia areata, androgenic alopecia and other non-scarring hair loss * The patient can read, understand, follow the examination procedures and complete, if necessary, the required documentation * Written informed consent

Exclusion criteria

* Acute or chronic diseases in the stage of decompensation * Chronic infectious diseases: HIV, viral hepatitis B, C, tuberculosis * Patients who are pregnant, breastfeeding, or fertile patients who are not using adequate contraceptive methods * Chronic and protracted mental disorders, all diseases with the presence of the syndrome of dependence on alcohol, drugs and psychoactive substances, any other condition that makes the patient unable to understand the nature, extent and possible consequences of the study or, in the opinion of the researcher, prevents the patient from observing and performing protocol * Patients are unable or unwilling to give written informed consent and / or follow research procedures * Any other medical condition that, in the opinion of the investigator, may be associated with an increased risk to the patient or may affect the outcome or evaluation of the study

Design outcomes

Primary

MeasureTime frameDescription
Number of cured patients6 monthNumber of cured patients with significant clinical improvement

Contacts

Primary ContactZinaida Kvacheva
kvachzb@tut.by+375173332223
Backup ContactHanna Paleshka
renovacio888@yandex.ru+375173332223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026